(Q74350106)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Kuromatsu I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Matsuo K

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Takamura S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kim G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Takebe Y

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kawamura J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Yasutomi Y

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

483-490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700330

10 November 2019

exact match

0 references

cites work

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

The biochemistry and cell biology of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Gene-modified tumor cells as cellular vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Genetically modified tumour vaccines--where we are today.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 cells leads to the local expression of macrophage inflammatory protein 1alpha and accumulation of dendritic cells at vaccination sites in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Combination gene therapy for liver metastasis of colon carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Characterization of the gene encoding the MPB51, one of the major secreted protein antigens of Mycobacterium bovis BCG, and identification of the secreted protein closely related to the fibronectin binding 85 complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

The novel fibronectin-binding motif and key residues of mycobacteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

BCG update: intravesical therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700330

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11498769%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference